Claudia Ordonez Keros Therapeutics, Inc. (KROS) insider trading activity
Claudia Ordonez is Chief Medical Officer of Keros Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KROS, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2021, when has been sold 1,000 shares (Common Stock) at a price of $51.22 per share, resulting in proceeds of $51,220. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Claudia Ordonez Transaction History
CO
Claudia Ordonez
Chief Medical Officer
Lexington, MA